Peginterferon beta-1a

• UNSPSC Description:

  Peginterferon beta-1a (Peginterferon β-1a) is the first pegylated interferon beta-1a molecule. Peginterferon beta-1a induces cancer cells apoptosis and shows anti-tumor activities in nude mice models. Peginterferon beta-1a can be used for the research of cancer and multiple sclerosis (RMS)[1].

• Target Antigen:

  Apoptosis

• Type:

  Reference compound

• Related Pathways:

  Apoptosis

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer; Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/peginterferon-beta-1a.html

• Solubility:

  10 mM in DMSO

• Smiles:

  [Peginterferon beta-1a]

• References & Citations:

  [1]Boccia A, et al. Peginterferon Beta-1a Shows Antitumor Activity as a Single Agent and Enhances Efficacy of Standard of Care Cancer Therapeutics in Human Melanoma, Breast, Renal, and Colon Xenograft Models. J Interferon Cytokine Res. 2017 Jan;37(1):20-31.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Launched

• CAS Number:

  1211327-92-2